Skip to search formSkip to main contentSkip to account menu

Provigil

Known as: Cephalon brand of modafinil 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

modafinil
modafinil 200 MG Oral Tablet [Provigil]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cognition enhancing drugs (‘nootropics’): time to include coaches and team executives in doping tests?
The use of brain boosting drugs by athletes has been well documented and testing for such cognition enhancing drugs is now… 
Review
2016
Review
2016
Non-Medical Use of Cognitive Enhancing Prescription Medications Among Occupational Therapy and Speech Language Pathology Health Care Students: A Pilot Study
Purpose: This research was designed to serve as a pilot study to generate baseline data on non-medical use of prescription drugs… 
Review
2014
Review
2014
A microdialysis and behavioural investigation of modafinil in freely moving rats
Review
2014
Review
2014
Subjective and reinforcing effects of modafinil in rats
2009
2009
Search for approaches to correction of daytime sleepiness induced by dopaminergic drugs during treatment of Parkinson’s disease: Neurochemical aspects
We proposed an approach to searching for a new drug that suppress increased daytime sleepiness induced by dopaminergic drugs… 
2008
2008
Conduite à tenir devant des accès paroxystiques douloureux chez un patient atteint d'un cancer et déjà sous opioïdes forts pour sa douleur de fond
* Unité d’évaluation et de traitement de la douleur, département d’anesthésie et de réani mation, hôpital européen Georges… 
2006
2006
Juicing the Brain: Research to limit mental fatigue among soldiers may foster controversial ways to enhance any person's brain
The article discusses the drugs being used to enhance performance and to limit mental fatigue among soldiers and its… 
2006
2006
Armodafinil Improves Daytime Wakefulness in CPAP Users
2005
2005
Conduct, Bipolar Disorder Often Comorbid With ADHD
Review
2003
Review
2003
Should a pharmaceutical be approved for the broad indication of excessive sleepiness?
In this issue of the AJRCCM (pp. 105–108), there is an interesting These attributes—demonstrated efficacy in promoting wakePro… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)